Stem Cell Therapy for Autism Only in Approved Clinical Trials: Centre, Pg16
Union Health Ministry restricts stem cell therapy for Autism Spectrum Disorder to approved clinical trials, citing lack of evidence and Supreme Court directives.
The Union Health Ministry issued an advisory on September 16, 2026, restricting the use of stem cell therapy for Autism Spectrum Disorder (ASD) to only duly approved clinical trials.
This directive mandates that stem cell therapy can be offered as standard clinical care only for disease conditions and indications explicitly approved by the Ministry.
The advisory follows a Supreme Court judgment dated January 30, 2026, in the case of Yash Charitable Trust & Ors. v. Union of India & Ors.
It reiterates the existing regulatory framework, including the Clinical Establishments (Registration and Regulation) Act, 2010, and the National Guidelines for Stem Cell Research, 2017.
Stem Cell Therapy.jpg
Detailed Insights:
The advisory aims to curb the unproven and commercial use of stem cell interventions for ASD due to a lack of established scientific evidence supporting them as a standard treatment.
An Indian Council of Medical Research (ICMR) review indicated that available evidence does not support stem cell therapy over behavioral and supportive therapies for ASD.
The Supreme Court judgment highlighted that administering stem cell therapy for ASD outside approved clinical trials is unethical and constitutes medical malpractice.
States and Union Territories that have adopted the Clinical Establishments (Registration and Regulation) Act, 2010, are required to disseminate these directions to regulatory authorities and clinical establishments.
Non-compliance with the regulatory framework can lead to consequences, including professional misconduct under medical regulations and actions under the Clinical Establishments Act, such as cancellation of registration.
The National Guidelines for Stem Cell Research, 2017, jointly issued by ICMR and the Department of Biotechnology (DBT), classify most stem cell therapies as investigational, requiring them to be conducted within approved clinical trials.
Scientific/Technical Concepts Involved:
Autism Spectrum Disorder (ASD): A neurodevelopmental disorder characterized by challenges in social interaction, communication, and repetitive behaviors.
Stem Cell Therapy: A regenerative medicine approach using undifferentiated cells to repair, replace, or regenerate damaged tissues and treat diseases.
Clinical Trials: Research studies conducted on human volunteers to evaluate the safety and efficacy of new medical treatments, drugs, or devices.